4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Palvella Therapeutics, Inc. (PVLA) operates in the Biotechnology industry and is headquartered in Wayne, United States with about 29 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, PVLA reported $0M in revenue and ($42M) in net income.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($39M) | ($14M) | ($12M) | ($18M) |
| Net Income | ($42M) | ($17M) | $19M | ($28M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($15M) | ($11M) | ($10M) | ($9M) | ($8M) |
| Net Income | ($16M) | ($13M) | ($11M) | ($10M) | ($8M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $60M | $88M | $8M | $16M |
| Total Liabilities | $32M | $26M | $11M | $40M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PVLA viewer.
About TickerBase · Data methodology & sources